Myofascial Release Reduces Rate of Elbow Joint Bleeding in Hemophilic Elbow Arthropathy Patients
How to Cite
OrthoEvidence. Myofascial Release Reduces Rate of Elbow Joint Bleeding in Hemophilic Elbow Arthropathy Patients. ACE Report. 2021;55(1):2. Available from: https://myorthoevidence.com/AceReport/Report/13712
Effects of myofascial release on frequency of joint bleedings, joint status, and joint pain in patients with hemophilic elbow arthropathy: A randomized, single-blind clinical trialMedicine (Baltimore). 2021 May 21;100(20): e26025.
Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here
Sixty-nine patients with hemophilic elbow arthropathy were included in this randomized controlled trial comparing 3 weeks of myofascial release therapy (n=35) to control (n=34) for the reduction of elbow joint hemarthrosis. The primary outcome of interest was the frequency of hemarthrosis. Secondary outcomes of interest included joint status on the hemophilia joint health score (HJHS) and joint pa...
Continuing Medical Education Credits
You could be earning 0.5 CME credits for each report you read.LEARN MORE